StockGlow

Ultragenyx Pharmaceutical Inc. (UP0.F)

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

21.47-0.05%Healthcare
Compare UP0.F with
StockGlow Score
21
Leaning Bearish
BearishBullish
1 year ago-9.8%

The outlook

Ultragenyx Pharmaceutical Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 31% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range31% of the way from its 52-week low to high
Market cap
$2.11B
52-wk high
34.00
52-wk low
15.90
50-day avg
23.76
200-day avg
22.85
Trailing P/E
—

Similar stocks

2L9.FVisionWave Holdings, Inc.$1.70-10.55%DR6.FACADIA Pharmaceuticals Inc.$22.88+1.15%4DN.MUDenali Therapeutics Inc.$20.80+0.00%38I.FIntellia Therapeutics, Inc.$9.16+0.77%4DN.FDenali Therapeutics Inc.$20.72-0.86%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy